Skip to main content
IXICO PLC logo

IXICO PLC — Investor Relations & Filings

Ticker · IXI ISIN · GB00BFXR4C20 LEI · 2138005M1F59O6HWSA97 IL Professional, scientific and technical activities
Open in API
Filings indexed 390 across all filing types
Latest filing 2026-05-22 Regulatory Filings
Country GB United Kingdom
Listing IL IXI

About IXICO PLC

https://www.ixico.com/

IXICO PLC is a clinical research and data analytics company specializing in neuroscience. It provides neuroimaging and digital biomarker analytics to biopharmaceutical firms conducting clinical trials for neurological disorders. The company utilizes its proprietary, AI-driven technology platform to manage and analyze complex imaging and digital health data. This platform deploys disease-specific algorithms to generate reliable clinical data and precision insights, aiming to accelerate research and development decision-making, de-risk clinical studies, and support the advancement of new therapies for conditions such as Alzheimer's and Huntington's disease.

Recent filings

Filing Released Lang Actions
Company presentation at Mello 2026
Regulatory Filings Classification · 87% confidence The document is a short RNS press release (3800 chars) announcing that IXICO will present at the Mello2026 investor event. It does not contain actual financial data, slides, or detailed presentation material—only a notice of an upcoming presentation. This falls under miscellaneous regulatory/press announcement that does not fit other categories. Therefore, it is classified as a Regulatory Filing (RNS).
2026-05-22 English
Contract win and contract extension
Regulatory Filings Classification · 90% confidence The document is an RNS press release announcing operational contract wins and extensions (Alzheimer’s and Phase 2 Huntington’s Disease clinical trial contracts) issued via the London Stock Exchange’s National Storage Mechanism. It contains no financial statements, no fundraising or M&A details, no dividend or share transactions, and no AGM/material attachments. This is a general regulatory announcement and does not constitute an earnings release, capital update, or detailed report. Therefore it falls under the fallback category for miscellaneous regulatory filings (RNS).
2026-05-21 English
Interim results for six months ending 31/03/2026
Earnings Release Classification · 89% confidence The document is an RNS announcement titled “Interim results for six months ending 31 March 2026” and contains unaudited half‐year financial highlights and narrative commentary (CEO statement, key metrics, operational updates). It does not present full statutory interim financial statements (P&L, balance sheet, cash flow) but rather the initial release of period results with key figures and strategic commentary. This matches an Earnings Release rather than a full Interim/Quarterly Report. H1 2026
2026-05-19 English
IXICO Updates AI Neuroimaging Platform
Regulatory Filings Classification · 70% confidence The document is an RNS announcement published via the London Stock Exchange’s Regulatory News Service, describing a product release (version 10 of IXICO’s AI-driven neuroimaging platform). It contains no financial statements, earnings data, voting or governance details, management changes, dividends, or other structured report content. It is a general regulatory/press release and does not fit specific categories like earnings release or annual report. Therefore it is classified under the fallback Regulatory Filings (RNS).
2026-05-12 English
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document is a UK FCA TR-1 form titled “Standard form for notification of major holdings” indicating an acquisition and crossing of voting rights thresholds for IXICO plc. It details the identity of the issuer, the shareholder, dates the threshold was crossed, percentages of voting rights and chain of controlled undertakings. This matches a Major Shareholding Notification (Code: MRQ).
2026-04-28 English
Holding(s) in Company
Major Shareholding Notification Classification · 95% confidence The document is an RNS TR-1 form notifying a change in major shareholdings (Octopus Investments Limited crossing the 17.42% to 19.15% threshold). It provides details of voting rights, dates of threshold crossing and notification, and standard regulatory disclosures for significant shareholding notifications. This matches the definition of a Major Shareholding Notification (MRQ).
2026-04-28 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.